doi: 10.3389/fendo.2020.623038 10 KivelaA
Cascio G, Aguirre KN, Church KP, Hughes RO, Nease LA, Delclaux I, et al
Peptides Antidepressants Combine Safe Research Context A Phase 2 trial published in Molecular Psychiatry in 2024 halted early after combining BPC-157 with fluoxetine in rodent models
The current generation of GLP 1 medications has already changed how clinicians think about weight, metabolism, and long term health, but researchers have always known that the biology of appetite is more complex than a single hormone pathway
Phage display peptide probes for imaging early response to bevacizumab treatment
doi: 10.1038/msb.2012.43 82 IgamberdievAUBykovaNV